Clinical Trial Detail

NCT ID NCT03158883
Title UCDCC#270: A Pilot Study of Avelumab and Stereotactic Ablative Radiotherapy in Non-responding and Progressing NSCLC Patients Previously Treated With a PD-1 Inhibitor
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements yes
Sponsors University of California, Davis
Indications

lung non-small cell carcinoma

Therapies

Avelumab

Age Groups: adult senior

Additional content available in CKB BOOST